{
  "id": 12313826,
  "title": "AbbVie, Genmab's Epcoritamab Plus R-CHOP Improves PFS In DLBCL",
  "url": "https://urgent.news/2026/10/06/abbvie-genmabs-epcoritamab-plus-r-chop-improves-pfs-in-dlbcl",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-06T05:19:03.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/abbvie-genmabs-epcoritamab-plus-r-chop-improves-pfs-dlbcl"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - AbbVie (ABBV) and Genmab (GMAB) reported positive topline results from the Phase 3 EPCORE DLBCL-2 trial evaluating epcoritamab plus R-CHOP in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL).",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}